Why Sarepta Therapeutics Tumbled Today

On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ: SRPT) stock fell by over 12% today. Investors were displeased with a company update about its fundamentals, and a new share issue.

In separate press releases, Sarepta gave investors a glimpse of its upcoming third-quarter earnings release, and provided details of that share issue.

Image source: Getty Images.

Continue reading

Source Fool.com